In line with the tumor-suppressive roles of IFNs, the disruption of lysine catabolism and the consequential activation of IFN signaling was associated with a decreased glioblastoma stem cell proportion in intracranial tumors.4 The gene discussed is IFNA1; the disease is glioblastoma.